For non-small lung cancer (NSCLC), in patients with a high preoperative serum CEA level, their postoperative serum CEA level has better prognostic value than their post/preoperative serum CEA ratio (Tomita et al., 2015). The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.